Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Birchmeier, Walter Prof. Dr. (4) Birchmeier-Kohler, Carmen Prof. Dr. (35) Blankenstein, Thomas Prof. Dr. (23) Daumke, Oliver Prof. Dr. (1) Filosa, Alessandro Dr. (1) Franke, Vedran Dr. (1) Gouti, Mina Dr. (1) Griffel, Carola (2) Grossmann, Katja Dr. (2) Haucke, Volker Professor (1) Jeuthe, Sarah Dr. (1) Kabuss, Loreen-Claudine (1) Kammertöns, Thomas Dr. (9) Kieback, Elisa Dr. (2) Kopp, Joachim Dr. (1) Kunz, Severine Dr. (2) Lahmann, Ines Dr. (1) Lewin, Gary Prof. Dr. (1) Müller, Dominik Prof. Dr. (1) Müller, Thomas Dr. (6) Pezzutto, Antonio Prof. Dr. (1) Rathjen, Fritz Prof. Dr. (1) Rybak-Wolf, Agnieszka Dr. (1) Sawamiphak, Suphansa Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (1) Spuler, Simone Prof. (2) Uckert, Wolfgang Prof. Dr. (6) Willimsky, Gerald Dr. (7) Wolf, Susanne Dr. (2) (-) Bunse, Mario Dr. (2) (-) Fischer, Cornelius Dr. (1) (-) Leisegang, Matthias Prof. Dr. rer. nat. (3) (-) Treier, Mathias Prof. Dr. (2) Bioinformatics and Omics Data Science (1) Bioinformatik der Genregulation (1) (-) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (3) Experimentelle Ultrahochfeld-MR (6) Genetik metabolischer und reproduktiver Störungen (3) Genom-Editierung & Krankheitsmodelle (3) Genomics (4) Immunregulation und Krebs (6) Magnetic Resonance (6) Mobile DNA (2) (-) Molekulare Immunologie und Gentherapie (7) Myologie (1) Proteom Dynamik (1) Proteomics (1) Proteomics and Metabolomics (1) Psychoneuroimmunologie (1) RNA Biologie und Posttranscriptionale Regulation (4) Stammzell-Modellierung der Entwicklung und Erkrankung (1) Transgenics (3) Zelluläre Neurowissenschaften (5) 2001 (1) 2005 (1) 2006 (1) (-) 2007 (2) (-) 2008 (1) (-) 2009 (1) (-) 2010 (1) 2011 (1) 2013 (3) 2015 (2) (-) 2016 (3) 2017 (1) 2018 (3) (-) 2020 (2) 2022 (1) 10 Ergebnisse: Active Filter: Bunse, Mario Dr.Fischer, Cornelius Dr.Leisegang, Matthias Prof. Dr. rer. nat.Treier, Mathias Prof. Dr.Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen Molekulare Immunologie und Gentherapie 200720082009201020162020 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner 01. März 2007 / Dev Biol Bmp and Wnt/beta-catenin signals control expression of the transcription factor Olig3 and the specification of spinal cord neurons D. Zechner T. Muller H. Wende I. Walther M.M. Taketo E.B. Crenshaw M. Treier W. Birchmeier C. Birchmeier 07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein 01. Januar 2009 / Development The bHLH transcription factor Olig3 marks the dorsal neuroepithelium of the hindbrain and is essential for the development of brainstem nuclei R. Storm J. Cholewa-Waclaw K. Reuter D. Broehl M. Sieber M. Treier T. Mueller C. Birchmeier 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein 17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein 07. Februar 2020 / EMBO Mol Med "Designer cytokines" targeting the tumor vasculature - think global and act local T. Kammertoens J. Kemna M. Leisegang 06. Februar 2020 / Cell Stem Cell Self-organizing 3D human trunk neuromuscular organoids J.M. Faustino Martins C. Fischer A. Urzi R. Vidal S. Kunz P.L. Ruffault L. Kabuss I. Hube E. Gazzerro C. Birchmeier S. Spuler S. Sauer M. Gouti 01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein 17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
15. April 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
01. März 2007 / Dev Biol Bmp and Wnt/beta-catenin signals control expression of the transcription factor Olig3 and the specification of spinal cord neurons D. Zechner T. Muller H. Wende I. Walther M.M. Taketo E.B. Crenshaw M. Treier W. Birchmeier C. Birchmeier
07. Juli 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
01. Januar 2009 / Development The bHLH transcription factor Olig3 marks the dorsal neuroepithelium of the hindbrain and is essential for the development of brainstem nuclei R. Storm J. Cholewa-Waclaw K. Reuter D. Broehl M. Sieber M. Treier T. Mueller C. Birchmeier
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
17. Oktober 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
07. Februar 2020 / EMBO Mol Med "Designer cytokines" targeting the tumor vasculature - think global and act local T. Kammertoens J. Kemna M. Leisegang
06. Februar 2020 / Cell Stem Cell Self-organizing 3D human trunk neuromuscular organoids J.M. Faustino Martins C. Fischer A. Urzi R. Vidal S. Kunz P.L. Ruffault L. Kabuss I. Hube E. Gazzerro C. Birchmeier S. Spuler S. Sauer M. Gouti
01. März 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
17. Mai 2016 / Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau